Evidence map›Paper›PMID 30519044›Full record

ArticleOncoTargets and therapy2018

miR-517a promotes Warburg effect in HCC by directly targeting FBP1.

Delin Zhang, Zhu Li, Tao Li, Dan Luo, Xinfu Feng, Yan Liu, Jianzhao Huang

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Delin ZhangDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Zhu LiDepartment of Hepatobiliary Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang 550002, China.
Tao LiDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Dan LuoDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Xinfu FengDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Yan LiuDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Jianzhao HuangDepartment of Hepatobiliary Surgery, Guizhou People's Hospital, Guiyang 550002, China, huangjzgph@163.com.
Guizhou Provincial People's Hospital · CNGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHepatocellular carcinoma (HCC) is one of the most aggressive malignancies worldwide. Our aim is to explore the expression and biological function of miR-517a in HCC. MATERIALS AND

methodsWe performed qRT-PCR to detect the expression of miR-517a in clinical samples and cell lines. CKK-8 assay and colony formation assay were employed to detect the miR-517a regulated cell proliferation. Glucose uptake and lactate production were examined to determine the Warburg effect. We also performed ECAR assay using Seahorse system. Luciferase acitivy assay was used to examine the binding of FBP1 3'UTR by miR-517a.

resultsmiR-517a was upregulated in HCC samples in both genomic and mRNA levels. Moreover, overexpression of miR-517a promoted cell proliferation and Warburg effect. Mechanically, miR-517a could directly target the 3'-UTR of FBP1. In addition, restoring the expression of FBP1 inhibited cell growth.

conclusionWe demonstrated that miR-517a acts as an oncogene to promote Warburg effect in HCC, favoring tumor growth, and miR-517a/FBP1 could be a novel target for HCC treatment.

Indexed as

FBP1HCCmiR-517aWarburg effect

Identifiers

PMID30519044
PMCPMC6239112
OpenAlexW2900629082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.